$1.68
-0.06-3.45%
At Close: -
$1.75
0.074.17%
After Hours: 9:26 AM EDT
15 minutes delayed
Aerovate Therapeutics
AVTENASDAQ
Aerovate Therapeutics (AVTE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAerovate Therapeutics (NASDAQ:AVTE) Stock Quotes, Forecast and News Summary
Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.
| Open | $1.73 |
| Close | $1.68 |
| Volume / Avg. | 476.02K / 1.08M |
| Day Range | 1.63 - 1.75 |
| 52 Wk Range | 1.25 - 32.42 |
| Market Cap | $50.44M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 24 |
| Short Interest | 18.84% |
| Days to Cover | 6.12 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Aerovate Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aerovate Therapeutics (AVTE) stock?
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Who are Aerovate Therapeutics (AVTE) competitors?
Other companies in Aerovate Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS) and BioLine Rx (NASDAQ:BLRX).
What is the target price for Aerovate Therapeutics (AVTE) stock?
There is no analysis for Aerovate Therapeutics.
What is the forecast for Aerovate Therapeutics (AVTE) stock?
Aerovate Therapeutics has a consensus price target of $7.78.
Current stock price for Aerovate Therapeutics (AVTE)?
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $1.7501 last updated Today at July 9, 2024 at 9:26 AM EDT.
Does Aerovate Therapeutics (AVTE) pay a dividend?
There are no upcoming dividends for Aerovate Therapeutics.
When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?
Aerovate Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Aerovate Therapeutics (AVTE) going to split?
There is no upcoming split for Aerovate Therapeutics.
What sector and industry does Aerovate Therapeutics (AVTE) operate in?
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.